Author:
Robles C,Kim KM,Oken MM,Bennett JM,Letendre L,Wiernik PH,O'Connell MJ,Cassileth PA
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference25 articles.
1. Cassileth PA, Lynch E, Hines JD, Oken MM, Mazza JJ, Bennett JM, McGlave PB, Edelstein M, Harrington DP, O'Connell MJ . Varying intensity of postremission therapy in acute myeloid leukemia Blood 1992 79: 1924–1930
2. Hiddeman W, Buchner T . Treatment strategies in acute myeloid leukemia (AML). B. Second line treatment Blut 1990 60: 163–171
3. Venditti A, Stasi R, Del Poeta G, Buccisano F, Aronica G, Bruno A, Pisani F, Caravita T, Masi M, Tribalto M, Simone MD, Avvisati G, Amadori S, Papa G . All-trans retinoic acid and low-dose cytarabine for the treatment of ‘poor prognosis’ acute myeloid leukemia Leukemia 1995 9: 1121–1125
4. Pascarella A, Marrani C, Leoni F, Ciolli S, Nozzoli C, Caporale R, Salti F, Ferrini PR . Low-dose cytosine arabinoside in patients with acute myeloid leukemia not eligible for standard chemotherapy Leuk Lymphoma 1995 18: 465–469
5. Slapak CA, Desforges JF, Fogaren T, Miller KB . Treatment of acute myeloid leukemia in the elderly with low-dose cytarabine, hydroxyurea, and calcitriol Am J Hematol 1992 41: 178–183
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献